University of Illinois at Chicago
Exemption #EWM536

Announcement of an Exempt Purchase

Award Info Published Monday August 31, 2026

Amerisource Receivables Financial Corp- DBA Cencora-Besse MedicalCincinnati, OH

  • Amount: An estimated $3,750,000
  • Terms: An estimated start date of 10/1/2026 through 9/30/2031
  • Renewals: None

Summary

Vendors

1 total
0 BEP vendors
0 VBP vendors
0 Small businesses

The University award process may be delayed as this award goes through a state approval process.

First published Monday, August 31, 2026
The University awarded a contract for Brixadi, a restricted, long acting medication.
Brixadi, a restricted, long acting medication used to treat high risk patients with Opioid Use Disorder
This purchase is exempt from the usual selection processes of the Procurement Code because the procurement expenditure is for medical supplies or medical at a university-operated health care center or dispensary that provides care, treatment, and medications for students, faculty and staff (30 ILCS 500 / 1-13(b-5)) medical supplies or medical at a university-operated health care center or dispensary that provides care, treatment, and medications for students, faculty and staff (30 ILCS 500 / 1-13(b-5))

For instructions on how to obtain a comprehensive purchase description, disclosure or contract forms, contact:
Eddie Mattox
University of Illinois Chicago
Purchasing Division (M/C 560)
809 South Marshfield Avenue
Chicago, IL 60612-7203
Phone: (312) 996-2054
FAX: (312) 996-2055

The State of Illinois has a policy to encourage prospective vendors to hire qualified veterans, minorities, females, persons with disabilities and ex-offenders.

Documents

No documents are available for this notice.